Colchicine;La colchicine

Annales de Medecine Interne

Volumn 147, Issue 3, 1996, Pages 185-211

  Le Hello, Claire ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE;

ALLERGY; ATHEROSCLEROSIS; BONE MARROW SUPPRESSION; CANCER; GASTROINTESTINAL DISEASE; GOUT; LIVER DISEASE; LUNG FIBROSIS; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PAGET BONE DISEASE; REVIEW; SKIN DISEASE;

COLCHICINE; GOUT SUPPRESSANTS; HUMANS;

EID: 0030056134     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (329)

1. LABORATOIRES HOUDE : La colchicine, aspects classiques et perspectives nouvelles, la colchicine cent ans après. Paris : Laboratoires Houdé, 1984 : 63.
2. MUZAFFAR A, BROSSI A : Chemistry of colchicine. Pharmacol Ther 1991 ; 49 : 105-9.
3. SABOURAUD A, ROCHDI M, URTIZBEREA M, CHRISTEN MO, ACHTERT G, SCHERRMANN JM : Pharmacokinetics of colchicine. A review of experimental and clinical data. Z Gastroenterol 1992 ; 30 (suppl 1) : 35-9.
4. DUSTIN P : Sur le centenaire de la découverte des proprié tés antimitotiques de la colchicine. Rev Med Brux 1989 ; 10 : 385-90.
5. MALKINSON FD : Colchicine. News uses of an old drug. Arch Dermatol 1982 ; 118 : 453-7.
6. EHRENFELD M, LEVY M, BAR ELI M, GAULLY R, ELIAKIM M : Effect of colchicine on polymorphonuclear leucocyte chemotaxis in human volunteers. Br J Clin Pharmacol 1980 ; 10 : 297-300.
7. MIYACHI Y, DANNO K, IMAMURA S : Suppression active Arthus reaction by colchicine. Br J Dermatol 1981 ; 105 : 279-83.
8. FAMAEY JP : Colchicine in therapy. State of the art and new perspectives for an old drug. Clin Exp Rheumatol 1988 ; 6 : 305-17.
9. LEVY M, SPINO M, READ SE : Colchicine : a state-of-the-art review. Pharmacotherapy 1991 ; 11 : 196-211.
10. SCHLESINGER M, ILFELD D, HANDZEL ZT et al : Effect of colchicine on immunoregulatory abnormalities in familial Mediterranean fever. Clin Exp Immunol 1983 ; 54 : 73-9.
11. ILFELD D, WEIL S, KUPERMAN O : Correction of a suppressor cell deficiency in familial Mediterranean fever by colchicine. Clin Exp Immunol 1981 ; 46 : 77-81.
12. ILFELD D, KUPERMAN O : Correction of a suppressor cell deficiency in four patients with familial Mediterranean fever by in vitro or in vivo colchicine. Clin Exp Immunol 1982 ; 50 : 99-106.
13. ILFELD D, THEODOR E, DELPIRE G, KUPERMAN O : In vitro correction of a deficiency of Con A-induced suppressor cell function in primary biliary cirrhosis by a pharmacological concentration of colchicine. Clin Exp Immunol 1984 ; 57 : 438-42.
14. OSTERMANN D, PERICO N, IMBERTI O, BARBUI C, BONTEM- PELLI M, REMUZZI G : Colchicine allows prolonged survival of highly reactive renal allograft in the rat. J Am Soc Nephrol 1993 ; 4 : 1294-9.
15. MlLNER LS, LOTAN D, MILLS M, GOODYER PR, FONG JS, KAPLAN BS : Colchicine reduces proteinuria in passive Heymann nephritis. Nephron 1987 ; 46 : 11-7.
16. LYONS MJ, AMADOR R, PETITO C, NAGASHIMA K, WEINREB H, ZABRISKIE JB : Inhibition of acute experimental allergic encephalomyelitis in mice by Colchicine. J Exp Med 1986 ; 164 : 1803-8.
17. NAIDUS RM, RODVIEN R, MIELKE H : Colchicine toxicity. A multisystem disease. Arch Intern Med 1977 ; 137 : 394-6.
18. HART J, LEWIN KJ, PETERS RS, SCHWABE AD : Effect of long-term colchicine therapy on jejunal mucosa. Dig Dis Sci 1993 ; 38 : 2017-21.
19. PETERS RS, LEHMAN TJ, SCHWABE AD : Colchicine use for familial Mediterranean fever : observations associated with long term treatment. West J Med 1983 ; 138 : 43-6.
20. KERSHENOBICH D, VARGAS F, GARCIA-TSAO G, PEREZ-TAMAYO R, GENT M, ROJKIND M : Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 1988 ; 318 : 1709-13.
21. KUNGL RW, DUNCAN G, WATSON D, ALDERSON K, ROGAWSKI MA, PEPER M : Colchicine myopathy and neuropathy. N Engl J Med 1987 ; 316 : 1562-8.
22. VAN DER NAALT J, HAAXMA-REICHE H, VAN DER BERG AP, HAZENBERG BP, MOLENAAR WM : Acute neuromyopathy after colchicine treatment. Ann Rheum Dis 1992 ; 51 : 1267-8.
23. RIEGER EH, HALASZ NA, WAHLSTROM HE : Colchicine neuromyopathy after renal transplantation. Transplantation 1990 ; 49 : 1196-8.
24. JONSSON J, GHLPI JR, LIGHT JA, AQUINO A, MASZAROS S : Colchicine-induced myoneuropathy in a renal transplant patient. Transplantation 1992 ; 53 : 1369-71.
25. BAUMELOU E, GUIGUET M, MARY JY : Epidemiology of aplastic anemia in France : a case-control study. Medical history and medication use. Blood 1993 ; 81 : 1471-8.
26. EHRENFELD M, LEVY M, MARGALIOTH EJ, ELIAKIM M : The effect of long-term colchicine therapy on male fertility in patients with familial Mediterranean fever. Andrologia 1986 ; 18 : 420-6.
27. BEN CHETRIT BE, LEVY M : Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years. Semin Arthritis Rheum 1991 ; 20 : 241-6.
28. MERLIN HE : Azoospermia caused by colchicine a case report. Fertil Steril 1972 ; 23 : 180-1.
29. LEVY M, YAFFE C : Testicular function in patients with familial mediterranean fever on long-term colchicine treatment. Fertil Steril 1978 ; 29 : 667-8.
30. FUKUTANI K, ISHIDA H, SHINOHARA M et al : Suppression of spermatogenesis in patients with Behçet's disease trea- ted with cyclophosphamide and colchicine. Fertil Steril 1981 ; 36 : 76-80.
31. BREMNER WJ, PAULSEN CA : Colchicine and testicular function in man. N Engl J Med 1976 ; 294 : 1384-5.
32. GHOZLAN R, PRAS M, BETTOUN A : Grossesse et stérilité au cours de la maladie périodique. Influence de la colchicine. Appréciation de son effet tératogène. Ann Med Interne 1981 ; 132 : 493-5.
33. Yu TF : The efficacy of colchicine prophylaxis in articular gout. A reappraisal after 20 years. Semin Arthritis Rheum 1982 ; 12 : 256-64.
34. ZEMER D, PRAS M, SOHAR E, GAFNI J : Colchicine in familial Mediterranean fever. N Engl J Med 1976 ; 294 : 170-1.
35. COHEN MM, LEVY M, ELIAKIM M : A cytogenetic evaluation of long term colchicine therapy in the treatment of familial Mediterranean fever. Am J Med Sci 1977 ; 274 : 147-52.
36. PUTTERMAN C, BEN-CHETRIT E, CARACO Y, LEVY M : Col- chicine intoxication : clinical pharmacology, risk factors, features and management. Semin Arthritis Rheum 1991 ; 21 : 143-55.
37. EHRENFELD M, BRZEZINSKI A, LEVY M, ELIAKIM M : Fertility and obstetric history in patients with familial Mediterranean fever on long-term colchicine therapy. Br J Obstet Gynaecol 1987 ; 94 : 1186-91.
38. RABINOVITCH O, ZEMER D, KUKIA E, SOHAR E, MASHIACH S : Colchicine treatment in conception and pregnancy : two hundred thirty-one pregnancies in patients with familial Mediterraenan fever. Am J Reprod Immunol 1992 ; 28 : 245-6.
39. COUSIN C, PALARIC JC, JACQUEMARD F, LUCAS J, GIRAUD JR : Maladie périodique et grossesse. J Gynecol Obstet Biol Reprod (Paris) 1991 ; 20 : 554-61.
40. BARAKAT MH, MUSTAFA HT, SHAKIR RA : Mollaret's meningitis. A variant of reccurent hereditary polyserositis, both provoked by metaraminol. Arch Neurol 1988 ; 45 : 926-7.
41. MORDEL N, BIRKENFELD A, RUBINGER D, SCHENKER JG, SADOVSKY E : Sucessful full-term pregnancy in familial Mediterranean fever complicated with amyloidosis : case report and review of the literature. Fetal Diagn Ther 1993 ; 8 : 129-34.
42. PRAS M, GAFNI J, JACOB ET : Progrès récents dans la maladie méditerranéenne familiale. Actual Nephrol Hop Necker (Paris) 1983 ; 30 : 175-83.
43. DUDIN A, RAMBAUD-COUSSON A, SHEHATTO M, THALJI A : Colchicine au cours du premier trimestre de la grossesse et malformations vertébrales. Arch Fr Pediatr 1989 ; 46 : 627-8.
44. MILLAIRE A, DE GROOTE P, DECOULX E, GOULLARD L, DUCLOUX G : Treatment of recurrent pericarditis with colchicine. Eur Heart J 1994 ; 15 : 120-4.
45. DUCLOUX G, MILLAIRE A, DE GROOTE P, DECOULX E, VAN BELLE E : La colchicine en pathologie cardiovasculaire. Sem Hop Paris 1992 ; 17 : 502-6.
46. BISMUTH C, GAULTIER M, CONSO F : Aplasie médullaire après intoxication aiguë à la colchicine. 20 cas. Nouv Presse Med 1977 ; 6 : 1625-9.
47. GAULTIER M, BISMUTH C, AUTRET A, PILLON M : Antidiurèse inappropriée après intoxication aiguë par la colchicine. 2 cas. Nouv Presse Med 1975 ; 4 : 3132-4.
48. STRINGFELLOW HF, HOWAT AJ, TEMPERLEY JM, PHILLIPS M : Waterhouse-Friderichsen syndrome resulting from colchicine overdose. J R Soc Med 1993 ; 86 : 680.
49. WALLACE SL, SINGER JZ : Review : systemic toxicity associated with the intravenous administration of colchicine. Guidelines for use. J Rheumatol 1988 ; 15 : 495-9.
50. ZEMER D, PRAS M, SOHAR E, MODAN M, CABILI S, GAFNI J : Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986 ; 314 : 1001-5.
51. KAPLAN MM, ALLING DW, ZIMMERMAN HJ et al : A prospective trial of Colchicine for primary biliary cirrhosis. N Engl J Med 1986 ; 315 : 1448-54.
52. CARACO Y, PUTTERMAN C, RAHAMIMOV R, BEN-CHETRIT E : Acute colchicine intoxication. Possible role of erythromycin administration. J Rheumatol 1992 ; 19 : 494-6.
53. SABOURAUD A, REDUREAU M, GIRES P, MARTINET M, SCHERRMANN JM : Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine. Drug Metab Dispos 1993 ; 27 : 997-1002.
54. SCHERRMANN JM, SABOURAUD A, URTIZBEREA M et al : Clinical use of colchicine-specific Fab fragments in colchicine poisoning. Vet Hum Toxicol 1992 ; 34 : 334.
55. BAUD FJ, SABOURAUD A, VICAUT E et al : Treatment of severe colchicine overdose with colchicine-specific Fab fragments. N Engl J Med 1995 ; 332 : 642-5.
56. MALAWISTA SE, BODEL PT : The dissociation by colchicine of phagocytosis from increased oxygen consumption in human leukocytes. J Clin Invest 1967 ; 46 : 786-96.
57. AHERN MJ, MCCREDIE M, REID C, BROOKS PM, GORDON TP, JONES M : Does colchicine work ? The results of the first controlled study in acute gout. Aust N Z J Med 1987 ; 17 : 301-4.
58. SOHAR E, GAFNI J, PRAS M, HELLER H : Familial Mediterranean fever A survey of 470 cases and review of the literature. Am J Med 1967 ; 43 : 227-53.
59. GAFNI J, RAVID M, SOHAR E : The role of amyloidosis in familial Mediterranean fever. A population study. Isr J Med Sci 1968 ; 4 : 995-9.
60. LUGASSY G, RONNEN M : Case report : severe pyoderma associated with familial Mediterranean fever. Favorable response to Colchicine in three patients. Am J Med Sci 1992 ; 304 : 29-31.
61. COLLARD M, SELLAL F; HIRSCH E, MUTSCHLER V, MARESCAUX C : Méningite récurrente aseptique au cours de la maladie périodique ou méningite de Mollaret ? Rev Neurol (Paris) 1991 ; 147 : 403-5.
62. GEDALIA A, ZAMIR S : Neurologic manifestations in familial Mediterranean fever. Pediatr Neurol 1993 ; 9 : 301-2.
63. VILASECA J, TOR J, GUARDIA J, BACARDI R : Periodic meningitis and familial Mediterranean fever. Arch Intern Med 1982 ; 142 : 378-9.
64. GOLDFINGER SE : Colchicine for familial Mediterranean fever. N Engl J Med 1972 ; 287 : 1302.
65. GOLDSTEIN RC, SCHWABE AD : Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study. Ann Intern Med 1974 ; 87 : 792-4.
66. ZEMER D, REVACH M, PRAS M et al : A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 1974 ; 297 : 932-4.
67. DlNARELLO CA, WOLFF SM, GOLDFINGER SE, DALE DC, ALLING DW : Colchicine therapy for familial Mediterranean fever. A double-blind trial. N Engl J Med 1974 ; 294 : 934-7.
68. WRIGHT DG, WOLFF SM, FAUCI AS, ALLING DW : Efficacy of intermittent Colchicine therapy in familial Mediterranean fever. Ann Intern Med 1977 ; 86 : 162-5.
69. LEVY M, ELIAKIM M : Long-term colchicine prophylaxis in familial Mediterranean fever. Br Med J 1977 ; 2 : 808.
70. KEDAR I, RAVID M, SOHAR E : Colchicine inhibition of casein induced amyloidosis in mice. Isr J Med Sci 1974 ; 10 : 787-9.
71. ZEMER D, LIVNEH A, LANGEVITZ P : Reversal of the nephrotic syndrome by Colchicine in amyloidosis of familial Mediterranean fever. Ann Intern Med 1992 ; 116 : 426.
72. RAVID M, ROBSON M, KEDAR I : Prolonged colchicine treatment in four patients with amyloidosis. Ann Intern Med 1977 ; 87 : 568-70.
73. MAAOUNI A, BEREICH A, HASSAR M, BENYAHIA D, KABBAJ M : Traitement de l'amyloidose par la colchicine. Rev Med Interne 1982 ; 3 : 59-63.
74. LIVNEH A, ZEMER D, SIEGAL B, LAOR A, SOHAR E, PRAS M : Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever. Nephrol 1992 ; 60 : 418-22.
75. SPEEG KV, MALDONADO AL : Effect of cyclosporine on colchicine partitioning in the rat liver. Cancer Chemother Pharmacol 1993 ; 32 : 434-6.
76. COHEN SL, BONER G, SHMUELI D, YUSIM A, ROSENFELD J, SHAPIRA Z : Cyclosporin : poorly tolerated in familial Mediterranean fever. Nephrol Dial Transplant 1989 ; 4 : 201-4.
77. SIEGAL B, ZEMER D, PRAS M : Cyclosporine and familial Mediterranean fever amyloidosis. Transplantation 1986 ; 41 : 793-4.
78. ISMAJOVICH B, ZEMER D, REVACH M, SERR DM, SOHAR E : The causes of sterility in females with familial Mediterranean fever. Fertil Steril 1973 ; 24 : 844-7.
79. DOR Y, HOMBURG R, RABAU E : An evaluation of etiologic factors and therapy in 665 infertile couples. Fertil Steril 1977 ; 28 : 718-22.
80. GRANAT M, TUR-KASPA I, ZYLBKR-KATZ E, SCHENKER GJ : Reduction of peritoneal adhesion formation by colchicine : a comparative study in the rat. Fertil Steril 1983 ; 40 : 369-72.
81. VERGOULAS G, PAPAGIANNIS A, TAKOUDAS D, PAPANIKOLAOU V, GAKIS D, ANTONIADIS A : Renal transplantation and pregnancy in a patient with familial Mediterranean fever amyloidosis taking triple-drug immunosuppression and colchicine. Nephrol Dial Transplant 1992 ; 7 : 273-4.
82. LEHMAN TJ, PETERS RS, HANSON V, SCHWABE AD : Long-term colchicine therapy of familial Mediterranean fever. J Pediatr 1978 ; 93 : 876-8.
83. MAJEED HA, CARROLL JE, KHUFFASH FA, HIJAZI Z : Long-term colchicine prophylaxis in children with familial Mediterranean fever (recurrent hereditary polyserositis). J Pediatr 1990 ; 116 : 991-9.
84. ZEMER D, LIVNEH A, DANON YL, PRAS M, SOHAR E : Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 1991 ; 34 : 973-7.
85. GLEDHILL RF, LEWIS PD, MARSDEN CD, RAKE MO : Is Mollaret's meningitis another periodic disorder responsive to colchicine ? Lancet 1975 ; 2 : 415.
86. MORA JS, GIMENO A : Mollaret meningitis : report of a case with recovery after colchicine. Ann Neurol 1980 ; 8 : 631-3.
87. CALVO MELENDRO JC : Mollaret's meningitis. Lancet 1975 ; 1 : 932-3.
88. STAMM AM, LIVINGSTON WK, GLENN COBBS C, DISMUKES WE : Failure of Colchicine in the treatment of Mollaret's meningitis. Arch Intern Med 1984 ; 144 : 2265-6.
89. LIVNEH A, ZEMER D, LANGEVITZ P, SHEMER J, SOHAR E, PRAS M : Colchicine in the treatment of AA and AL amyloidosis. Semin Arthritis Rheum 1993 ; 23 : 206-14.
90. FRITZ DA, LUGGEN ME, HESS EV : Unusual longevity in primary systemic amyloidosis. A 19-year survivor. Am J Med 1989 ; 86 : 245-8.
91. SCHAFFNER A, VARON D, GREEN L, HERWITZ N, BENTWICH Z : Primary amyloidosis with unusual bone involvement : reversibility with melphalan, prednisone and colchicine. Am J Med 1989 ; 86 : 347-8.
92. COHEN AS, RUBINOW A, ANDERSON JJ et al. : Survival of patients with primary (AL) amyloidosis. Colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973). Am J Med 1987 ; 82 : 1182-90.
93. KYLE RA, GREIPP PR : Primary systemic amyloidosis : comparaison of melphalan and prednisone versus placebo. Blood 1978 ; 52 : 818-27.
94. KYLE RA, GREIPP PR, CARTON JP, GERTZ MA : Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine. Am J Med 1985 ; 79 : 708-16.
95. BENSON MD. Treatment of AL amyloidosis with melphalan, prednisone, and colchicine. Arthritis Rheum 1986 ; 29 : 683-7.
96. DE WAZIÈRES B, FEST T, HUMBERT P, VUITTON D, DUPOND JL : Amylose familiale de type AL et déficit en facteur X. Intérêt de la colchicine au long cours. Ann Med Interne 1990 ; 141 : 388-90.
97. MEYERS S, JANOWITZ HD, GUMASTE VV et al. : Colchicine therapy of the renal amyloidosis of ulcerative colitis. Gastroenterology 1988 ; 94 : 1503-7.
98. RAVID M, SCHAPIRA J, KEDAR I, FEIGL D : Regression of amyloidosis secondary to granulomatous ileitis following surgical resection and colchicine administration. Acta Hepatogastroenterol 1979 ; 26 : 513-5.
99. ESCALANTE A, EHRESMANN GR, QUISMORIO FP : Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine. Arthritis Rheum 1991 ; 34 : 920-2.
100. MATSUMURA N, MIZUSHIMA Y : Leucocyte movement and colchicine treatment in Behçet's disease. Lancet 1975 ; 1 : 813.
101. MIZUSHIMA Y, MATSUMURA N, MORI M : Chemotaxis of leukocytes and colchicine treatment in Behçet's disease. J Rheumatol 1979 ; 6 : 108-10.
102. JORIZZO JL, HUDSON RD, SCHMALSTIEG FC, DANIELS JC, APISARNTHANARAX P, HENRY JC : Behçet's syndrome : immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy. J Am Acad Dermatol 1984 ; 70 : 205-14.
103. PRONAI L, ICHIKAWA Y, NAKAZAWA H, ARIMORI S : Enhanced Superoxide generation and the decreased Superoxide scavenging activity of peripheral blood leukocytes in behçet's disease. Effect of colchicine. Clin Exp Rheumatol 1991 ; 9 : 227-33.
104. HASHIMOTO T, TAKEUCHI A : Treatment of Behçet's disease. Curr Opin Rheumatol 1992 ; 4 : 31-4.
105. AKTULGA E, ALTAC M, MÜFTÜOGLU A, ÖZYAZGAN Y, PAZARLI H, TÜZÜN Y : A double blind study of colchicine in Behçet's disease Haematologica 1980 ; 65 : 399-402.
106. MIZUSHIMA Y, MATSUMURA N, MORI M, SHIMIZU T et al : Colchicine in Behçet's disease. Lancet 1977 ; 2 : 1037.
107. RAYNOR A, ASKARI AD : Behçet's disease and treatment with colchicine. J Am Acad Dermatol 1980 ; 2 : 396-400.
108. HAZEN PG, MICHEL B : Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behçet's syndrome. Arch Dermatol 1979 ; 115 : 1303-6.
109. MIYACHI Y, TANIGUCHI S, OZAKI M, HORIO T : Colchicine in the treatment of the cutaneous manifestations of Behçet's disease. Br J Dermatol 1981 ; 104 : 67-9.
110. SANDER HM, RANDLE HW : Use of colchicine in Behçet's syndrome. Cutis 1986 ; 37 : 344-8.
111. VORDERMARK JS, HUDSON LD : Behçet's disease with genitourinary involvement treated with colchicine. Urology 1984 ; 23 : 290-2.
112. MATLOFF DS, ALPERT E, RESNICK RH, KAPLAN MM : A prospective trial of D penicillamine in primary biliary cirrhosis. N Engl J Med 1982 ; 306 : 319-26.
113. MUZULU SI, WALTON S, KECZKES K : Colchicine therapy in Behçet's syndrome. A report of five cases, Clin Exp dermalol 1989 ; 14 : 298-9.
114. DE Bois MH, GEELHOED-DUIJVESTIJN PH, WESTEDT ML : Behçet's syndrome treated with colchicine. Neth J Med 1991 ; 38 : 175-6.
115. TAFI L, MATUCCI CERINIC M, FALCINI F, VALENTINI G, BARTOLOZZI G : Colchicine treatment of Behçet's disease in children. Arthritis Rheum 1987 ; 30 : 1435.
116. THI HUONG Du L, FAIN O, WECHSLER B et al. : Intérêt des « bolus » de cyclophosphamide dans la maladie de Behçet. Expérience de 17 cas. Presse Med 1990 ; 19 : 1355-8.
117. GRAHAM-BROWN RA, SARKANY I : Failure of colchicine and fibrinolytic therapy in Behçet's disease. Clin Exp Dermatol 1980 ; 5 : 87-92.
118. FOSSALUZZA V : Colchicine and arthropathy of Behçet's disease. Arthritis Rheum 1982 ; 25 : 1509.
119. BENNOUNA-BIAZ F, HEID E, LAZRAK B : Maladie de Behçet. Essai de traitement par la colchicine. Ann Dermatol Venereol (Paris) 1982 ; 109 : 593-4.
120. HIJKATA K, MASUDA K : Visual prognosis in Behçet's disease : effects of cyclosphophamide and colchicine. Jpn J Ophtalmol 1978 ; 22 : 506-19.
121. KAZOKOGLU H, SAATCI O, CUHADAROGLU H, ELDEM B : Long-term effects of cyelophosphamide and colchicine treatment in Behçet's disease. Ann Ophtalmol 1991 ; 23 : 148-51.
122. TESSLER HH, JENNINGS T : High dose, short term chlorambucil for intractable sympathetic ophtalmia and Behçet's disease. Br J Ophtalmol 1990 ; 74 : 353-7.
123. YAZICI H, PAZARLI H, BERNES GG et al. : A controlled trial of azathioprine in Behçet's disease. N Engl J Med 1990 ; 322 : 281-5.
124. MASUDA K, NAKAJIMA A, URAYAMA A, NAKAE K, KOGURE M, INABA G : Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet 1989 ; 1 : 1093-6.
125. DE MERIEUX P, SPITLER LE, PAULUS HE : Treatment of Behçet's syndrome with levamisole. Arthritis Rheum 1981 ; 24 : 64-70.
126. HAMZA MH, AYED K, BEN AYKD H : Treatment of Behçet's disease with levamisole. Arthritis Rheum 1982 ; 25 : 714-5.
127. LAVERY HA, PINKERTON JH : Successful treatment of Behçet's syndrome with levamisole. Br J Dermatol 1985 ; 113 : 372-3.
128. SAYLAN T, SALTIK I : Thalidomide in the treatment of Behçet's syndrome. Arch Dermatol 1982 ; 118 : 536.
129. SHARQUIE KE : Suppression of Behçet's disease with dapsone. Br J Dermatol 1984 ; 110 : 493-4.
130. CONVIT J, GOIHMAN-YAHR M, RONDON-LOGO AJ : Effectiveness of dapsone in Behçet's disease. Br J Dermatol 1984 ; 111 : 629-30.
131. HOUSSET E : Intérêt de certains dérivés de la colchicine dans le traitement des syndromes sclérodermiformes. Ann Dermatol Venereol (Paris) 1967 ; 94 : 31-4.
132. ALARCON-SEGOVIA D, IBANEZ G, KERSHENOBICH D, ROJKIND M : Treatment of scleroderma. Lancet 1974 ; 1 : 1054-5.
133. ALARCON-SEGOVIA D, RAMOS-NIEMBRO F, IBANEZ DE, KASEP G, ALCOCER J, PEREZ-TAMAYO R : Long-term evaluation of colchicine in the treatment of scleroderma. J Rheumatol 1979 ; 6 : 705-12.
134. HARPEY JP, RENAULT F, ROY C, LAFOURCADE J : Sclérodermie de l'enfant. Traitement par la colchicine. Nouv Presse Med 1980 ; 9 : 2844.
135. FUCHS D, FRUCHTER L, FISHEL B, HOLTZMAN M, YARON M : Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis. Clin Rheumatol 1986 ; 5 : 527-30.
136. FERNANDEZ-HERMIHY L : Skin elasticity and colchicine in scleroderma. Arthritis Rheum 1976 ; 19 : 832-3.
137. GUTTADAURIA M, DIAMOND H, KAPLAN D : Colchicine in the treatment of scleroderma. J Rheumatol 1977 ; 4 : 272-6.
138. DIEPPE PA, KIRBY JD : Colchicine in the treatment of systemic sclerosis. Eur J Rheumatol 1979 ; 2 : 248-9.
139. FRAYA RA : Colchicine therapy in scleroderma. Preliminary results. Dermatologica 1979 ; 159 : 78-81.
140. MEDSGER TA : Treatment of systemic sclerosis. Dermatologica 1989 ; 15 : 513-31.
141. STEEN VD, MEDSGER TA, RODNAN GP : D Penicillamine therapy in progressive systemic sclerosis (scleroderma). A retrospective analysis. Ann Intern Med 1982 ; 97 : 652-9.
142. STEEN VD, OWENS GR, REDMOND C, RODMAN GP, MEDSGER TA : The effect of D-penicillamine on pulmonary findings in systemic sclerosis. Arthritis Rheum 1985 ; 28 : 882-8.
143. DE CLERCK LS, DEQUEKER J, FRANCX L, DEMEDTS M : D Penicillamine therapy and interstitial lung disease in scleroderma. A long-term follow-up study. Arthritis Rheum 1987 ; 30 : 643-50.
144. BECKETT VL, CONN DL, FUSTER V et al. : Trial of platelet- inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin. Arthritis Rheum 1984 ; 27 : 1137-43.
145. VAN DEN HOOGEN FH, BOERBOOMS AM, VAN DE PUTTE LB : Methotrexate treatment in scleroderma. Am J Med 1989 ; 87 : 116-7.
146. FURST DE, CLEMENTS PJ, HILLIS S et al. : Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study. Arthritis Rheum 1989 ; 32 : 584-93.
147. BLACK CM : Systemic sclerosis : Is there a treatment yet ? Ann Rheum Dis 1990 ; 49 : 735-7.
148. KAHAN A, AMOR B, MENKES CJ, STRAUCH G : Recombinant Interferon gamma in the treatment of systemic sclerosis. Am J Med 1989 ; 87 : 273-7.
149. TABORN J, BOLE GG, THOMPSON GR : Colchicine suppression of local and systemic inflammation due to calcinosis universalis in chronic dermatomyositis. Ann Intern Med 1978 ; 89 : 648-9.
150. STALDER JF, DAVID A, COHEN JY : Dermatomyosite de l'enfant. Utilisation de la colchicine au cours des poussées de calcinose. Presse Med 1984 ; 13 : 441.
151. CALLEN JP, CHANDA JJ, VOORHEES JJ : Cutaneous angiitis (vasculitis). Int J Dermatol 1978 ; 17 : 105-13.
152. CALLEN JP : Colchicine is effective in controlling chronic cutaneous leukocytodastic vasculitis. J Am Acad Dermatol 1985 ; 13 : 193-200.
153. CALLEN JP : Oral colchicine therapy is effective for chronic cutaneous leukocytoclastic vasculitis. Arthritis Rheum 1987 ; 30(suppl 4): S106.
154. CALLEN JP, AF EKENSTAM E : Cutaneous leukocytodastic vasculitis : clinical experience in 44 patients. South Med J 1987 ; 80 : 848-51.
155. BARASH J, COOPER M : Chronic cutaneous vasculitis in a C3-deficient patient treated with colchicine. Isr J Med Sci 1993 ; 29 : 310-1.
156. PLOTNICK S, HUPPBRT AS, KANTOR G : Colchicine and leukocytoclastic vasculitis. Arthritis Rheum 1989 ; 32 : 1489-90.
157. CUPPS TR, SPRINGER RM, FAUCI AS : Chronic, reccurent small-vessel cutaneous vasculitis. Clinical experience in 13 patients. JAMA 1982 ; 247 : 1994-8.
158. WILES JC, HANSEN RC, LYNCH PJ : Urticarial vasculitis treated with colchicine. Arch Dermatol 1985 ; 121 : 802-5.
159. WERNI R, SCHWARZ TH, GSCHNAIT F : Colchicine treatment of urticarial vasculitis. Dermatologica 1986 ; 172 : 36-40.
160. ASHERSON RA, BUCHANAN N, KENWRIGHT S, FLETCHER CM, HUGHES GR : The normocomplementemic urticarial vasculitis syndrom report of a case and response to colchicine. Clin Exp Dermalol 1991 ; 16 : 424-7.
161. ASHERSON RA, D'CRUZ D, STEPHENS CJ, MC KEE PH, HUGHES GR : Urticarial vasculitis in a connective tissue disease clinic : patterns, presentations, and treatment. Semin Arthritis Rheum 1991 ; 20 : 285-96.
162. BORRADORI L, RYBOJAD M, WEISS L, SPATH P, PUISSANT A, MOREL P : Urticaire chronique et hypocomplémentémie acquise due à un facteur néphrétique (C3 NeF). Schweiz Med Wochenschr 1990 ; 720 : 1236-41.
163. LAWLOR F, KOBZA BLACK A, MILFORD WARD A, MORRIS R, GREAVES MW : Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine. Br J Dermalol 1989 ; 120 : 403-8.
164. KERSHENOBICH D, ROJKIND M, QUIROGA A, ALCOCER-VARELA J : Effect of colchicine on lymphocyte and monocyte function and its relation to fibroblast proliferation in primary biliary cirrhosis. Hepatology 1990 ; 11 : 205-9.
165. MILLER LC, KAPLAN MM : Serum interleukin 2 and tumor necrosis factor alpha in primary biliary cirrhosis : decrease by colchicine and relationship to HLA-DR4. Am J Gastroenterol 1992 ; 87 : 465-70.
166. WARNES TW, SMITH A, LEE F, HABOUBI NY, JOHNSON PJ, HUNT L : A controlled trial of colchicine in primary biliary cirrhosis. Hepatology 1984 ; 4 : 1022.
167. WARNES TW, SMITH A, LEE FI, HABOUBI NY, JOHNSON PJ, HUNT L : A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report. J Hepatol 1987 ; 5 : 1-7.
168. BODENHEIMER H, SCHAFFNER F, PEZZULLO J : Evaluation of colchicine therapy in primary biliary cirrhosis. Gastroenterology 1988 ; 95 : 124-9.
169. ZIFRONI A, SCHAFFNER F : Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy. Hepatology 1991 ; 14 : 990-3.
170. POUPON R, POUPON RE, CALMUS Y, CHRÉTIEN Y, BALLET F, DARNIS F : Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis ? Lancet 1987 ; 1 : 834-6.
171. POUPON RE, BALKAU B, ESCHWEGE E, POUPON R : A multicenter controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991 ; 324 : 1548-54.
172. SHIBATA J, FUJIYAMA S, HONDA Y, SATO T : Combination therapy with ursodeoxycholic acid and colchicine for primary biliary cirrhosis. J Gastroenterol Hepatol 1992 ; 7 : 277-82.
173. MITCHISON HC, BASSENDINE MF, MALCOM AJ, WATSON AJ, RECORD CO, JAMES OF : A pilot, double-blind, controlled one year trial of prednisolone treatment in pri- mary biliary cirrhosis : hepatic improvement but greater bone loss. Hepatology 1989 ; 10 : 420-9.
174. JAIN S, SAMOURIAN S, SCHEVER PJ, O'D MC GEE J : A controlled trial of D-penicillamine therapy in primary biliary cirrhosis. Lancet 1977 ; 1 : 831-4.
175. EPSTEIN O, LEE RG, BOSS AM et al. : D-penicillamine treatment improves survival in a primary biliary cirrhosis. Lancet 1981 ; 1 : 1275-7.
176. BODENHEIMER HC, SCHAFFNER F, STERNLIEB I, KLION FM, VERNACE S, PEZZULLO J : A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis. Hepatology 1985 ; 5 : 1139-42.
177. DICKSON ER, FLEMING TR, WIESNER RH et al. : Trial of penicillamine in advanced primary biliary cirrhosis. N Engl J Med 1985 ; 312 : 1011-5.
178. NEUBERGER J, CHRISTENSEN E, PORTMANN B et al. : Double-blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis. Gut 1985 ; 26 : 114-9.
179. HEATHCOTE J, ROSS A, SHERLOCK S : A prospective controlled trial of azathioprine in primary biliary cirrhosis. Gastroenterology 1976 ; 70 : 656-60.
180. CHRISTENSEN E, NEUBERGER J, CROWE J et al. : Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Gastroenterology 1985 ; 89 : 1084-91.
181. HOOFNAGLE JH, DAVIS GL, SCHAFER DF et al. : Randomized trial of chlorambucil for primary biliary cirrhosis. Gastroenterology 1986 ; 91 : 1327-334.
182. KAPLAN MM, KNOX TA, ARORA S : Primary biliary cirrhosis treated with low-dose oral pulse methotrexate. Ann Intern Med 1988 ; 109 : 429-31.
183. ROUTHIER G, JANOSSY G, EPSTEIN O et al : Effects of cyclosporin A on suppressor and inducer T lymphocytes in primary biliary cirrhosis. Lancet 1980 ; 2 : 1223-6.
184. WIESNER RH, LUDWIG J, LINDOR KD et al. : A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med 1990 ; 322 : 1419-24.
185. LINDOR KD, WIESNER RH, COLWELL LJ, STEINER B, BEAVER S, LA RUSSO NF : The combination of prednisone and colchicine in patients with primary sclerosing cholangitis. Am J Gastroenterol 1991 ; 86 : 57-61.
186. LA RUSSO N, WIESNER R, LUDWIG J : Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 1988 ; 95 : 1036-42.
187. KAPLAN MM, ARORA S, PINCUS SH : Primary sclerosing cholangitis and low-dose oral pulse methotrexate therapy : clinical and histologic response. Ann Intern Med 1987 ; 106 : 231-5.
188. BACHRACH WH, HOKMANN AF : Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Dig Dis Sci 1982 ; 27 : 833-56.
189. STIEHL A, RAEDSCH R, KOMMERELL B : The effect of ursodeoxycholic acid (urso) in primary sclerosing cholangitis : a comparison to primary biliary cirrhosis (abstract). Gastroenterology 1988 ; 94 : 595.
190. ASKARI AD : Colchicine for treatment of relapsing polychondritis. J Am Acad Dermatol 1984 ; 10 : 507-10.
191. SCIOLLA JP, GUILLOT B, GUILHOU JJ, MEYNADIER J, BARJON P : Traitement de la polychondrite chronique atrophiante par la colchicine. Rev Med Interne 1986 ; 7 : 334.
192. ZHANG L, ZHU Y, LUO W, XI P, YAN Y : The protective effect of colchicine on bleomycin-induced pulmonary fibrosis in rats. Chin Med Sci J 1992 ; 7 : 58-60.
193. RENNARD SI, BITTERMAN PB, OZAKI T, ROM WN, CRYSTAL RG : Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro : the basis of a possible therapeutic approach to the fibrotic disorders. Am Rev Respir Dis 1988 ; 137 : 181-5.
194. PETERS SG, MC DOUGALL JC, DOUGLAS WW, COLES D, DE REMEE RA : Colchicine in the treatment of pulmonary fibrosis.Chest 1993 ; 103 : 101-4.
195. TURNER-WARWICK M, BURROWS B, JOHNSON A : Cryptogenic fibrosing alveolitis response to corticosteroid treatment and its effect on survival. Thorax 1980 ; 35 : 593-9.
196. KEOGH BA, BERNARDO J, HUNNING HAKE GW, LINE BR, PRICE DL, CRYSTAL RG : Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis. Am Rev Respir Dis 1983 ; 127 : 18-22.
197. WINTERBAUER RH, HAMMAR SP, HALLMAN KO et al. : Diffuse interstitial pneumonitis : clinicopathologic correlations in 20 patients treated with prednisone, azathioprine. Am J Med 1978 ; 65 : 661-72.
198. RAGHU G, DEPASO WJ, CAIN K, HAMMAR SP, WETZEL CE, DREIS DF : Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis : a prospective double-blind, randomized, placebo-controlled trial. Am Rev Respir Dis 1991 ; 144 : 291-6.
199. WINTERBAUER RH : The treatment of idiopathic pulmonary fibrosis. Chest 1991 ; 100 : 233-5.
200. DOMINGUEZ-MALAGON HR, ALFEIRAN-RUIZ A, CHAVARRIA-XICOTENCATL P, DURAN-HERNANDEZ MS : Clinical and cellular effects of colchicine in fibromatosis. Cancer 1992 ; 69 : 2478-83.
201. AKKUS E, CARRIER S, REHMAN J, BREZ A, KADIOGLU A, LUE TF : Is colchicine effective in Peyronie's disease ? A pilot study. Urology 1994 ; 44 : 291-5.
202. KAPLAN H : Sarcoid arthritis with a response to colchicine. N Engl J Med 1960 ; 263 : 778-81.
203. KAPLAN H : Further experience with colchicine in the treatment of sarcoid arthritis. N Engl J Med 1963 ; 268 : 761-4.
204. BUNIM JJ, KIMBERG DV, THOMAS LB : The syndrome of sarcoidosis, psoriasis, and gout. Ann Intern Med 1962 ; 57 : 1018-39.
205. ZVAIFLER NJ, PEKIN TJ : Signifiance of urate crystals in synovial fluid. Arch Intern Med 1963 ; 111 : 99-102.
206. WALLACH SL, BERSTEIN D, DIAMOND H : Diagnostic value of the colchicine therapeutic trial. JAMA 1967 ; 799 : 525-8.
207. HARRIS ED, MILLIS M : Treatment with colchicine in the periarticular inflammation associated with sarcoidosis : a need for continued appraisal. Arthritis Rheum 1971 ; 14 : 130-3.
208. EHRENFELD M, MILLER M, SORIC R, BAUM J, TENENBAUM J : Intravenous colchicine in acute sarcoid arthropathy. J Rheumatol 1984 ; 11 : 412-3.
209. WYSENBEEK AJ, SCHOENFELD N, EPSTEIN O, GREENBLAT Y, ATSMON A : Inhibition of experimental porphyria with colchicine. Int J Biochem 1985 ; 17 : 937-40.
210. WYSENBEEK AJ, SCHOENFELD N, LEIBOVICI L, ATSMON A : Colchicine treatment of abdominal pains in porphyric patients. Isr J Med Sci 1989 ; 25 : 95-7.
211. FESTEN JJ, KUIPERS JC, SCHAARS AH : Multifocal reccurent periostitis responsive to colchicine. Scand J Rheumatol 1985 ; 74 : 8-14.
212. INVERNIZZI F : Colchicine and mixed cryoglobulinemia. Arthritis Rheum 1993 ; 36 : 722-3.
213. WALLACE SL : Erythema nodosum : treatment with colchicine. JAMA 1967 ; 202 : 144.
214. SAROJINI PA, MSHANA RN : Use of colchicine in the management of erythema nodosum leprosum (ENL). Lepr Rev 1983 ; 54 : 151-3.
215. SHARMA VK, KUMAR B, KAUR I, SINGH M, KAUR S : Colchicine in the treatment of type 2 lepra reaction. Indian J Lepr 1986 ; 58 : 43-7.
216. STANLEY JN, KIRAN KU, PEARSON JM : The use of colchicine in the management of type 2 lepra reaction (erythema nodosum leprosum). Lepr Rev 1984 ; 55 : 317-8.
217. KAR HK, ROY RG : Comparison of colchidne and aspirin in the treatment of type 2 lepra reaction. Lepr Rev 1988 ; 59 : 201-3.
218. TAKIGAWA M, MIYACHI Y, UEHARA M, TAGAMI H : Treatment of pustulosis palmaris et plantaris with oral doses of colchicine. Arch Dermatol 1982 ; 118 : 458-60.
219. BERBIS P, DEHARO C, PRIVAT Y : Ostéite rhumatismale aseptique associée à la pustulose palmo-plantaire. Intérêt de la colchicine. Presse Med 1988 ; 17 : 1410-1.
220. THESTRUP-PEDERSEN K, REYMANN F : Treatment of pustulosis palmaris and plantaris with colchicine. A double-blind cross-over trial. Acta Derm Venereol 1984 ; 64 : 76-8.
221. MANN RJ : Failure of colchicine for palmo-plantar pustulosis. Br J Dermatol 1982 ; 106 : 373.
222. ENGLISH JS, FENTON DA, WILKINSON JD : Failure of colchicine for palmo-plantar pustulosis. Clin Exp Dermatol 1983; 8 : 207-9.
223. VAN SCOTT EJ, REINERTSON RP : Morphologic and physiologic effects of Chemotherapic agents in psoriasis. J Invest Dermatol 1959 ; 33 : 357-69.
224. KAIDBEY KH, PETROZZI JW, KLIGMAN AM : Topical colchicine therapy for recalcitrant psoriasis. Arch Dermatol 1975 ; 111 : 33-6.
225. WAHBA A, COHEN H : Therapeutic trials with oral colchicine in psoriasis. Acta Dermatol Venereol (Stockholm) 1980 ; 60 : 515-20.
226. ZACHARIAE H, KRAGBALLE K, HEREIN T : Colchicine in generalized pustular psoriasis : clinical response and antibody-dependant cytotoxicity by monocytes and neutrophils. Arch Dermatol Res 1982 ; 274 : 327-33.
227. HORIGUCHI M, TAKIGAWA M, IMAMURA S : Treatment of generalized pustular psoriasis with methotrexate and colchicine. Arch Dermatol 1981 ; 117 : 760.
228. SEIDEMAN P, FJELLNER B, JOHANNESSON A : Psoriatic arthritis treated with oral colchicine. J Rheumatol 1987 ; 14 : 777-9.
229. MC KENDRY RJ, KRAAG G, SEIGEL S, AL-AWADHI A : Therapeutic value of colchicine in the treatment of patients with psoriatic arthritis. Ann Rheum Dis 1993 ; 52 : 826-8.
230. ANTOINE JC, MAURICE M, FELDMAN G, AVRAMEAS S : In vivo and in vitro effects of colchicine and vinblastine on the secretory process of antibody-producing cells. J Immunol 1980 ; 125 : 1939-49.
231. THOMPSON AE, DABROWSKA-BERNSTEIN : Inhibition by colchicine of human lymphocytotoxic function : dependance on cell bound drug level, spontaneous reversibility and by desacetylcolchicine. Leuk Res 1983 ; 7 : 175-92.
232. WOODLEY DT, BURGKSON RE, LUNSTRUM G, BRUCKNER-TUDERMAN L, REESE MJ, BRIGGAMANN RA : Epidermolysis bullosa acquisita antigen is the globular carboxy terminus of type VII procollagen. J Clin Invest 1988 ; 81 : 683-7.
233. SILVERS DM, JUHLIN EA, BERCZELLER PH, MC SORLEY J : Treatment of dermatitis herpetiformis with colchicine. Arch Dermatol 1980 ; 116 : 1373-4.
234. BERBIS P, PRIVAT Y : Intérêt de la colchicine dans le traitement de l'épidermolyse hulleuse acquise. Ann Dermatol Venereol 1989 ; 116 : 301-7.
235. MEGAHED M, SCHARFFETTER KOCHANEK K : Epidermolysis bullosa acquisita, successful treatment with colchicine. Arch Dermatol Res 1994 ; 286 : 35-46.
236. LAMBERT D, BEER F, GODARD W, DALAC S, CHAVANET P, PORTIER H : Lupus érythémateux vésiculo-bulleux. Étude immuno-électronique. Ann Dermatol Venereol 1986 ; 113 : 665-9.
237. ARAM H : Linear IgA bullous dermatosis successful treatment with colchicine. Arch Dermatol 1984 ; 120 : 960-1.
238. ZEHARIA A, HODAK E, MUKAMEL M, DANZIGER Y, MIMOUNI M : Successful treatment of chronic bullous dermatosis of childhood with colchicine. J Am Acad Dermatol 1994 ; 30 : 660-1.
239. GENGOUX P, TENNSTEDT D, LACHAPELLE JM : Intraepidermal neutrophilic IgA dermatosis : pemphigus-like IgA deposits. Dermatology 1992 ; 185 : 311-3.
240. SUEHISA S, TAGAMI H : Treatment of acute febrile neutrophilic dermatosis (Sweet's syndrome) with colchicine. Br J Dermatol 1981 ; 105 : 483.
241. SUEHISA S, TAGAMI H, INOUE F, MATSUMOTO K, YOSHIKUNI K : Colchicine in the treatment of acute febrile neutrophilic dermatosis (Sweet's syndrome). Br J Dermatol 1983 ; 108 : 99-101.
242. BAJWA RP, MARWAKA RK, GAREWAL G, RAJAGOPALAN M : Acute febrile neutrophilic dermatosis (Sweet's syndrome) in myelodysplastic syndrome. Pediatr Hematol Oncol 1993 ; 10 : 343-6.
243. DJIAN B, SANTONI A, GUILHON JJ et al : Traitement de l'aphtose vulgaire récidivante par la colchicine. Nouv Presse Med 1982 ; 11 : 3799.
244. GATOT A, TOVI F : Colchicine therapy in recurrent oral ulcers. Arch Dermatol 1984 ; 120 : 994.
245. RUAH CB, STRAW JR, CHASIN WD : Traitement de l'aphtose buccale récidivante par la colchicine. Arch Otolaryngol 1988 ; 34 : 197-201.
246. KATZ J, LANGEVITZ P, SHEMER J, BARAK S, LIVNEH A : Prevention of recurrent aphtous stomatitis with colchicine : an open trial. J Am Acad Dermatol 1994 ; 31 : 459-61.
247. VON KROGH G, RUDEN AK : Topical treatment of penile condylomata acuminata with colchicine at 48-72 hours intervals. Acta Dermatol Venereol (Stockholm) 1980 ; 60 : 87-9.
248. PINQUIER L, REVUZ J : Traitement de l'aphtose buccale récidivante. Ann Dermatol Venerol 1987 ; 114 : 751-7.
249. LEHNER T, WILTON JM, IVANYI L : Double-blind cross over trial of levamisole in recurrent aphtous ulcerations. Lancet 1976 ; 2 : 926-9.
250. DE MEYER J, DEGRAEVE M, CLARYSSE J, DE LOOSE F, PEREMANS W : Levamisole in aphtous stomatitis : evaluation of three regimens. Br Med J 1971 ; 1 : 671-4.
251. GRINSPAN D : Signifiant response of oral aphtosis to thalidomide treatment. J Am Acad Dermatol 1985 ; 12 : 85-90.
252. GENVO MF, FAURE M, THIVOLET J : Traitement de l'aphtose par la thalidomide et la colchicine. Dermatologica 1984 ; 168 : 182-8.
253. PEACOCK EE : Pharmacologic control of surface scarring in human beings. Ann Surg 1981 ; 193 : 592-7.
254. LAWRENCE WT : In search of the optimal treatment of keloids. Report of a series and a review of the literature. Ann Plast Surg 1991 ; 27 : 164-78.
255. GIGAX JH, ROBINSON JR : The successful treatment of intraurethral condyloma acuminata with colchicine. J Urol 1971 ; 105 : 809-11.
256. VON KROCH G : Topical treatment of penile condylomata acuminata with podophyllin, podophyllotoxin and colchicine. Acta Dermatol Venereol (Stockholm) 1978 ; 58 : 163-8.
257. SPILBERG I, BERNEY S : Colchicine and pseudogout. Arthritis Rheum 1979 ; 22 : 427-8.
258. MEED SD, SPILBERG I : Successful use of colchicine in acute polyraticular pseudogout. J Rheumatol 1981 ; 8 : 689-91.
259. SPILBERG I, MC LAIN D, SIMCHOWITZ L, BERNEY S : Colchicine and pseudogout. Arthritis Rheum 1980 ; 23 : 1062-3.
260. TABATABAI MR, CUMMINGS NA : Intravenous colchicine in the treatment of acute pseudogout. Arthritis Rheum 1980 ; 23 : 370-4.
261. SPILIOTIS TE : Colchicine and chronic pseudogout. Arthritis Rheum 1981 ; 24 : 862-3.
262. GONZALEZ T : Colchicine and pseudogout. Arthritis Rheum 1982 ; 25 : 1509-10.
263. ALVARELLOS A, SPILBERG I : Colchicine prophylaxis in pseudogout. J Rheumatol 1986 ; 13 : 804-5.
264. THOMPSON GR, TING YM, RIGGS GA, FENN ME, DENNING RM : Calcific tendinitis and soft tissue calcification resembling gout. JAMA 1968 ; 203 : 464-72.
265. THEODORS A, ASKARI AD, WIELAND RG : Colchicine in the treatment of Paget disease of bone : a new therapeutic approach. Clin Ther 1981 ; 3 : 365-73.
266. CRISP AJ, HAZLEMAN BL : Colchicine in Paget's disease. Clin Rheumatol 1985 ; 4 : 365-6.
267. KHAIRI MR, ALTMAN RD, DE ROSA GP, ZIMMERMANN J, SCHENK RK, JOHNSTON CC : Sodium etidronate in the treatment of Paget's disease of bone : a study of long term results. Ann Intern Med 1977 ; 87 : 656-63.
268. SCHWARTZBERG M : Prophylactic colchicine therapy in palindromic rheumatism. J Rheumatol 1982 ; 9 : 341-3.
269. ELIAKIM A, NEUMANN L, HOROWITZ J, BUSKILA D, KLEINER-BAUMGERTEN A, SUKENIK S : Palindromic rhumatism is Israël. A disease entity ? A survey of 34 patients. Clin Rheumatol 1989 ; 8 : 507-11.
270. MATUCI-CERINIC M, CERUSO M, LOTTI T, PIGNONE A, JAJIC I : The medical and surgical treatment of finger clubbing and hypertrophic osteoarthropathy. A blind study with colchicine and a surgical approach to finger clubbing reduction, Clin Exp Rheumatol 1992 ; 10 (suppl 7) : 67-70.
271. MATUCI-CERINIC M, FATTORINI L, GERINI G et al. : Colchicine treatment in a case of pachydermoperiostosis with acroosteolysis. Rheumatol Inst 1988 ; 8 : 185-8.
272. RASK MR : Colchicine use in the damaged disk syndrome (DOS). Report of 50 patients, Clin Onthop 1979 ; 143 : 183-90.
273. RASK MR : Colchicine use in 3 000 patients with diskal (and other) painful spinal disorders. J Neurol Orthop Med Surg 1985 ; 6 : 295-302.
274. SCHNEBEL BE, SIMMONS JW : The use of oral colchicine for low-back pain. A double-blind study. Spine 1988 ; 13 : 354-7.
275. HOUSSET E : Intérêt thérapeutique de la colchicine en pathologie vasculaire périphérique. Angeiologie 1962 ; 5 : 21-2.
276. MICHOT MP : Le Colchimax® dans les affections veineuses périphériques. Rev Med Dijon 1968 ; 3 : 139.
277. JOUACHIM Y : Utilisation de la colchicine dans le traitement des lymphœdèmes superficiels des membres. Essai de synthèse clinique et thérapeutique à partir de 33 observations. Actual Angeiol 1982 ; 7 : 9-14.
278. RODRIGUEZ DE LA SERNA A, SOLDEVILA JG, CLARAMUNT VM, BAYES DE LUNA A : Colchicine for recurrent pericarditis. Lancer 1987 ; 2 : 1517.
279. GUINDO J, RODRIGUEZ DE LA SERNA A, RAMIO J et al : Recurrent pericarditis, relief with colchicine. Circulation 1990 ; 82 : 1117-20.
280. ADLER Y, ZANDMAN-GODDARD G, RAVID M et al. : Usefulness of colchicine in preventing recurrences of pericarditis. Am J Cardiol 1994 ; 73 : 916-7.
281. DUCLOUX G, MILLAIRE A, TISON E, DEGROOTE P, DECOULX E : Intérêt de la colchicine dans les péricardites inflammatoires et leurs récidives. Presse Med 1991 ; 20 : 223-4.
282. MILLAIRE A, DUCLOUX G : Treatment of acute or recurrent pericarditis with colchicine before using Corticosteroids. Eur Heart J 1993 ; 14 : 1438.
283. DOUCHET MP, ATTALI P, FINCKER JL : A case of recurrent benign pericarditis treated by colchicine. Eur Heart J 1993 ; 14 : 431-2.
284. SPODICK DH : Colchicine therapy of recurrent pericarditis. Circulation 1991 ; 83 : 1830-1.
285. CHALDAKOV GN : Antitubulins a new therapeutic approach for atherosclerosis ? Atherosclerosis 1982 ; 44 : 385-90.
286. GODEAU G, GONNORD G, WEGROWSKI J, POMPIDOU A, SCHOVAERT D, ROBERT L : Effect of colchicine on atherosclerosis. Study of dermal elastic fibers by quantitative histochemistry, automated image analysis. Clin Physiol Biochem 1985 ; 3 : 234-9.
287. BAURIEDEL G, WINDSTETTER U, SCHÖNKE H, PÖLNITZ A, KANDOLF R, HÖFLING B : Colchicine reduces mobility of smooth muscle cells cultivated from human plaques (abstract). Circulation 1989 ; 80 (suppl 2) : 128.
288. HOLLANDER W, PADDOCK J, NAGRAT S, COLOMBO MA, KIRPATRICK B : Effects of anticalcifying and antifibrotic drugs on preestablished atherosclerosis in the rabbit. Atherosclerosis 1919 ; 33 : 111-23.
289. CURRIER JW, POW TK, MINIHAN AC, HAUDENSCHILD DC, FAXON DP, RYAN JJ : Colchicine inhibits restenosis after iliac angioplasty in the atherosclerosis rabbit (abstract). Circulation 1989 ; 80 (suppl 2) : 66.
290. LAGRUE G, WEGROSKI J, RHABAR K et al. : Effect of colchicine on atherosclerosis. Clinical and biological studies. Clin Physiol Biochem 1985 ; 3 : 221-5.
291. WEGROWSKI J, MOCZAR M, LAGRUE G, RHABAR K, ROBERT AM, ROBERT L : Effect of colchicine on atherosclerosis. Biochemical studies on skin biopsies from patients treated perorally with colchicine. Clin Physiol Biochem 1985 ; 3 : 226-33.
292. GRINES CL, RIZIK D, LEVINE A, SCHREIBER T, GANGADHARAN V, RAMOS R : Colchicine angioplasty restenosis trial. Circulation 1991 ; 84 (suppl 2) : 365.
293. O'KEEFE JH, MC CALLISTER BD, BATEMAN TM, KUHNLEIN DL, LIGON RW, HARTZLER GO : Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol 1992 ; 19 : 1597-600.
294. MULLER DW, ELLIS SG, TOPOL EJ : Colchicine and antineoplastic therapy for the prevention of restenosis after percutaneous coronary interventions. J Am Coll Cardiol 1991 ; 17 (6 suppl B) : 126B-31B.
295. HERMANS WR, RENSING BJ, STRAUSS BH, SERRUYS PW : Prevention of restenosis after percutaneous transluminal coronary angioplasty : The search for a « magic bullet ». Am Heart J 1991 ; 122 : 171-87.
296. GOTTUEB NB, GOTTLIEB RS, MORGANROTH J, BROZOVICH FV : prevention of restenosis after PTCA by angiotensin converting enzyme inhibitors. J Am Coll Cardiol 1991 ; 17: 181A.
297. POO JL, FELDMANN G, MOREAU A, GAUDIN C, LEBREC D : Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation. J Hepatol 1993 ; 19 : 90-4.
298. ROJKIND M, URIBE M, KERSHENOBICH D : Colchicine and the treatment of liver cirrhosis. Lancet 1973 ; 1 : 38-9.
299. KERSHENOBICH D, URIBE M, SUAREZ GI, MATA JM, PEREZTAMAYO R, ROJKIND M : Treatment of cirrhosis with colchieine. A double-blind randomized trial. Gastroenterology 1979 ; 77 : 532-6.
300. BOYER JL, RANSOHOFF DF : Is colchicine effective therapy for cirrhosis ? N Engt J Med 1988 ; 318 : 1751-2.
301. FULLER RK, SCHOEN RE, GORDIS E, KERSHENOBICH D : Colchicine in the treatment of cirrhosis. N Engl J Med 1988 ; 319 : 1285-6.
302. GRACE ND : Colchicine treatment of cirrhosis : questions. Hepatology 1989 ; 9 : 655-6.
303. ALBORNOZ-PLATA A : Treatment of cirrhosis of the liver with colchicine. Study of 14 years. Gastroenterology 1991 ; 100 (part 2) : pA2.
304. AKRIVIADIS EA, STEINDEL H, PINTO PC et al. : Failure of colchicine to improve short term survival in patients with severe alcoholic hepatitis. Gastroenterology 1990 ; 99 : 811-8.
305. TRINCHET JC, BEAUGRAND M, CALLARD P et al. : Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial. Gastroenterol Clin Biol 1989 ; 73 : 551-5.
306. MICHEL H, LARREY D, BLANC P : Le traitement de l'hépatite alcoolique aiguë. Ann Gastroenterol Hepatol (Paris) 1993 ; 29 : 29-39.
307. RESNICK RH, BOINOTT J, IBER FL : Preliminary observations of D-penicillamine therapy in acute alcoholic liver disease. Digestion 1974 ; 11 : 257-65.
308. ISCH-WALL P : Quatre cas de maladie de Hodgkin traités par la colchicine. Sang Biol Pathol 1952 ; 23 : 689-93.
309. GROLLMAN A, JOHNSON RL, REGAN WW : A clinical evaluation of colchicine in the treatment of Hodgkin's disease. Ann Intern Med 1955 ; 42 : 154-70.
310. THOMPSON AE, ROBINSON MA : Cytocidal action of colchicine in vitro on lymphocytes in chronic lymphocytic leukemia. Lancet 1967 ; 2 : 868-70.
311. THOMPSON AE, O'CONNOR TW, WETHERLEY-MEIN G : Killing and characterizing action of colchicine in vitro on lymphocytes of chronic lymphocytic leukemia. Scand J Haematol 1972 ; 9 : 231-47.
312. SCHREK R, MESSMORE HL, KNOSPE WH, STEFANI SS : A colchicine sensitivity test for leukemic lymphocytes. Scand J Haematol 1976 ; 16 : 357-64.
313. WEICK JK, LIVINGSTON RB, VAN SLYCK EJ : Colchicine in refractory chronic lymphocytic leukemia. A Southwest oncology group study. Invest New Drugs 1983 ; 1 : 335-8.
314. SCHREK R, MOLNAR Z, STEFANI SS : Cytology and colchicine sensitivity of viable cells from lymph nodes with malignant lymphoma. Cancer 1978 ; 41 : 1845-56.
315. SANDERS PW : Potential role of colchicine in the prevention of cast nephropathy from Bences-Jones proteins. Contrib Nephrol 1993 ; 101 : 104-8.
316. CAIRNS HS, DAWNAY A, WOOLFSON RG, UNWIN RJ : Evaluation of therapy for cast nephropathy : failure of colchicine to alter urinary Tamm-Horsfall glycoprotein excretion in normal subjects. Exp Nephrol 1994 ; 2 : 257-8.
317. STROTHER SV, ZUCKERMAN KS, LO BUGLIO AF : Colchicine therapy for refractory idiopathic thrombocytopenic purpura. Arch Intern Med 1984 ; 144 : 2198-200.
318. BAKER RI, MANOHARAN A : Colchicine therapy for idiopathic thrombocytopenic purpura, an inexpensive alternative. Aust N Z J Med 1989 ; 79 : 412-3.
319. MARWAHA RK, SINGH RP, GAREWAL G, MARWAHA N, PRAKASH D, SARODE R : Colchicine therapy in immune thrombocytopenic purpura. Acta Paediatr Scand 1990 ; 79 : 1118-20.
320. ANONYMOUS : Five year results in 90 eases of breast cancer following combined treatment with colchicine derivatives, mastectomy and postoperative radiotherapy. Chin Med J 1980 ; 93 : 227-30.
321. HU E, KO R, KODA R et al. : Phase I toxicity and pharmacology study of trimethylcolchicinic acid in patients with advanced malignancies. Cancer Chemother Pharmacol 1990 ; 26 : 359-64.
322. CAMPS, PASBEAU : Une ḿdication anti-inflammatoire nouvelle en pathologie ORL (à propos de 167 observations). Cah Otorhinolaryngol 1969 ; 4 : 361-6.
323. APPAIX A, LISBONIS JM : Le colchimax® comme anti-inflammatoire en ORL (à propos de 50 observations). Cah Otorhinolaryngol 1970 ; 5 : 805-8.
324. BELLAVIA WD : Treatment with intravenous colchicine. Cranio 1991 ; 9 : 49-57
325. ILFELD D, KIVITY S, FEIERMAN E, TOPILSKY M, KUPERMAN O : Effect of in vitro colchicine and oral theophylline on suppressor cell function of asthmatic patients. Clin Exp Immunol 1985 ; 61 : 360-7.
326. SCHWARZ YA, KIVITY S, ILFELD DN et al. : A clinical and immunologic study of colchicine in asthma. J Allergy Clin Immunol 1990 ; 85 : 578-82.
327. COHEN AB, GIRARD W, MC LARTY J et al. : A controlled trial of colchicine to reduce the elastase load in the lungs of ex-cigarette smokers with obstructive pulmonary disease. Am Rev Respir Dis 1991 ; 143 : 1038-43.
328. GAUGAN I. Effect of colchicine in diabetic neuropathy. A clinical and EMG study. Rom J Neural Psychiatry 1985 ; 23 : 199-201.
329. DAS U. Colchicine in diabetes mellitus. J Assoc Physicians India 1993 ; 41 : 213.